Cytiva
Danaher life sciences division — ReadyToProcess single-use bioprocess systems, WAVE bioreactors, and chromatography for biologics manufacturing.
- Country
- United States
- Revenue
- ~$3.8B
- Employees
- ~10,000 emp
FDA GMP
ISO 9001
Coverage
| CN | EU | US | |
|---|---|---|---|
| analytics-pat | ✓ | ✓ | ✓ |
| cleanroom-facilities | ✓ | ✓ | ✓ |
| consumables | ✓ | ✓ | ✓ |
| downstream-purification | ✓ | ✓ | ✓ |
| upstream-bioreactors | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Bioprocess analytics & PAT (process analytical technology) | analytics-pat | Low | → |
| Downstream Purification & Bioseparation | downstream-purification | Low | → |
| Media manufacturing (B2B production equipment) | cleanroom-facilities | Low | → |
| Microcarriers for adherent cell cultures | consumables | Low | → |
| Single-use assemblies | consumables | Low | → |
| Single-use bag bioreactors (50L-2000L) | upstream-bioreactors | Low | → |
| Single-use bioprocessing & modular factories | upstream-bioreactors | Low | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.